rs1252273429
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_022041.4(GAN):c.112G>A(p.Gly38Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000699 in 1,431,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022041.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAN | NM_022041.4 | c.112G>A | p.Gly38Arg | missense_variant | Exon 1 of 11 | ENST00000648994.2 | NP_071324.1 | |
GAN | NM_001377486.1 | c.-413G>A | 5_prime_UTR_variant | Exon 1 of 10 | NP_001364415.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAN | ENST00000648994.2 | c.112G>A | p.Gly38Arg | missense_variant | Exon 1 of 11 | NM_022041.4 | ENSP00000497351.1 | |||
GAN | ENST00000648349.2 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 10 | ENSP00000498114.1 | |||||
GAN | ENST00000650388.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 9 | ENSP00000498081.1 | |||||
GAN | ENST00000674788.1 | n.237G>A | non_coding_transcript_exon_variant | Exon 1 of 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.99e-7 AC: 1AN: 1431072Hom.: 0 Cov.: 32 AF XY: 0.00000141 AC XY: 1AN XY: 711206
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Giant axonal neuropathy 1 Uncertain:1
Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with GAN-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 38 of the GAN protein (p.Gly38Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at